Use KOMEN20 for 20% off
How It Works
How It Works
Solutions for Libido Loss: New Moves
Try new positionsPosition during intercourse can be crucial. Lying on your side, with your partner entering from behind, is considered the least stressful to the vagina (with the least degree of pe...
Communicating to Others About Long-Term Side Effects: Katie Shaw-Younkerman
When Katie Shaw-Younkerman was diagnosed with breast cancer, she took a leave of absence from her job. But even after treatment, she has found that long-term effects from treatment impact her abili...
Sponsored Clinical Trials
Clinical trials study how well a new treatment or procedure works in people. The studies are done under careful supervision and help doctors identify the best treatments with the fewest side effect...
Why You Should Consider Scalp Cooling
Krysten Gentile was diagnosed with early-stage breast cancer in 2017. In this blog, she discusses the decision to protect her hair using cold caps, her experience with them, and why she recommends ...
Volunteer Spotlight: Katie Parker
Volunteers make our work possible. This month, we’re spotlighting volunteer Katie Parker, from Rapid City, South Dakota, a member of LBBC's Young Advocate program.
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM). Tamoxifen is approved by the U.S. Food and Drug Administration (FDA) to treat: women and men diagnosed with...
Sharing Knowledge: Pairing Experts With Patient Advocates
Talking to Family About Your Breast Cancer Diagnosis
LBBC board member and founder of AnaOno Dana Donofree speaks to AnaOno team member and LBBC Young Advocate Dani Bennov about sharing her diagnosis with her family, navigating treatment with them by...
SPoT-Light HER2 CISH Test
SPoT-Light HER2 CISH, which stands for Subtraction Probe Technology Chromogenic In Situ Hybridization, is a test used see if breast cancer cells are HER2-positive. HER2-positive cells have too many...
Prosigna Breast Cancer Prognostic Gene Signature Assay
The Prosigna Breast Cancer Prognostic Gene Signature Assay (formerly called the PAM50 test), made by NanoString, is a genomic test that analyzes the activity of certain genes in early-stage, hormon...
Oncotype DX Test
The Oncotype DX test is a genomic test that analyzes the activity of a group of genes that can affect how a cancer is likely to behave and respond to treatment. The Oncotype DX is used in two ways:...
Why Can't I Wear Deodorant to My Mammogram?
When you schedule a mammogram, you’ll hear what’s become standard advice for the day of your screening: don’t wear underarm deodorant or antiperspirant. The same goes for any powders, creams, or lo...
Breastcancer.org Mammogram Recommendations
Breastcancer.org believes that all medical decisions, including if and when to screen for breast cancer, are decisions to be made by each woman and her doctor.The value of screening mammograms was ...
Mammography: Benefits, Risks, What You Need to Know
Mammograms don’t prevent breast cancer, but they can save lives by finding breast cancer as early as possible. The value of screening mammograms was questioned in November 2009 when the U.S. Preven...
The MammaPrint test, made by Agendia, is a genomic test that analyzes the activity of certain genes in early-stage breast cancer. Research suggests the MammaPrint test may eventually be widely us...
IHC Tests (ImmunoHistoChemistry)
IHC, or ImmunoHistoChemistry, is a special staining process performed on fresh or frozen breast cancer tissue removed during biopsy. IHC is used to show whether or not the cancer cells have HER2 re...
FISH Test (Fluorescence In Situ Hybridization)
Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is don...
The EndoPredict Test, offered by Myriad Genetics, Inc., is a genomic test for people newly diagnosed with early-stage, estrogen-receptor-positive, HER2-negative breast cancer. Research suggests t...
CDK4/6 Inhibitor Plus Aromatase Inhibitor Helps Treat Breast Cancer, No Matter a Woman’s Age
An analysis of three studies on different CDK4/6 inhibitors in combination with an aromatase inhibitor to treat postmenopausal women diagnosed with metastatic, hormone-receptor-positive, HER2-negat...
Sentinel Lymph Node Biopsy Offers No Benefits for Older Women With DCIS
Older women diagnosed with DCIS see no long-term benefits from having sentinel lymph node biopsy to see if the cancer has spread beyond the breast to the lymph nodes, according to a study by Yale U...